Abstract
Heat Shock Protein 90 (Hsp90) is a ubiquitous molecular chaperone that comprises about 1–3% of the total cellular protein. Over the last decade, Hsp90 has been detected and studied in the extracellular space (extracellular or eHsp90) of normal and neoplastic cells. Once outside the cell, eHsp90 has been shown to interact with extracellular client proteins and promote their stabilization and function. Cell conditioned media are routinely collected to detect and quantify eHsp90, and determine its interactions with extracellular clients. Finally, targeting specifically the eHsp90 with pharmacologic inhibitors or antibodies that are unable to cross the plasma membrane has been beneficial in inhibiting tumor cell motility and invasion.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Rohl A, Rohrberg J, Buchner J (2013) The chaperone Hsp90: changing partners for demanding clients. Trends Biochem Sci 38:253–262
Taipale M, Jarosz DF, Lindquist S (2010) HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11:515–528
Vartholomaiou E, Echeverria PC, Picard D (2016) Unusual suspects in the twilight zone between the Hsp90 interactome and carcinogenesis. Adv Cancer Res 129:1–30
Woodford MR, Dunn D, Miller JB, Jamal S, Neckers L, Mollapour M (2016) Impact of posttranslational modifications on the anticancer activity of Hsp90 inhibitors. Adv Cancer Res 129:31–50
Eustace BK, Sakurai T, Stewart JK et al (2004) Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 6:507–514
McCready J, Wong DS, Burlison JA, Ying W, Jay DG (2014) An impermeant ganetespib analog inhibits extracellular Hsp90-mediated cancer cell migration that involves lysyl oxidase 2-like protein. Cancers (Basel) 6:1031–1046
Tsutsumi S, Neckers L (2007) Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci 98:1536–1539
Dong H, Zou M, Bhatia A et al (2016) Breast cancer MDA-MB-231 cells use secreted heat shock protein-90alpha (Hsp90alpha) to survive a hostile hypoxic environment. Sci Rep 6:20605
Suzuki S, Kulkarni AB (2010) Extracellular heat shock protein HSP90beta secreted by MG63 osteosarcoma cells inhibits activation of latent TGF-beta1. Biochem Biophys Res Commun 398:525–531
Li J, Soroka J, Buchner J (2012) The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones. Biochim Biophys Acta 1823:624–635
Wong DS, Jay DG (2016) Emerging roles of extracellular Hsp90 in cancer. Adv Cancer Res 129:141–163
Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E (2008) A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J Biol Chem 283:2031–2041
Stellas D, El Hamidieh A, Patsavoudi E (2010) Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. BMC Cell Biol 11:51
Sims JD, McCready J, Jay DG (2011) Extracellular heat shock protein (Hsp)70 and Hsp90alpha assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One 6:e18848
Song X, Wang X, Zhuo W et al (2010) The regulatory mechanism of extracellular Hsp90{alpha} on matrix metalloproteinase-2 processing and tumor angiogenesis. J Biol Chem 285:40039–40049
Bourboulia D, Stetler-Stevenson WG (2010) Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20:161–168
Stellas D, Karameris A, Patsavoudi E (2007) Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis. Clin Cancer Res 13:1831–1838
Tsutsumi S, Scroggins B, Koga F et al (2008) A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 27:2478–2487
Wang X, Song X, Zhuo W et al (2009) The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci U S A 106:21288–21293
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Cortes, S., Baker-Williams, A., Mollapour, M., Bourboulia, D. (2018). Detection and Analysis of Extracellular Hsp90 (eHsp90). In: Calderwood, S., Prince, T. (eds) Chaperones. Methods in Molecular Biology, vol 1709. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7477-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7477-1_23
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7476-4
Online ISBN: 978-1-4939-7477-1
eBook Packages: Springer Protocols